Institute for Protein Design
The Institute for Protein Design develops novel proteins using artificial intelligence and computational methods for applications in medicine, therapeutics, sustainable chemistry, and environmental remediation. It aims to create custom-designed enzymes and protein structures to address challenges such as gene therapy delivery, biocatalysis, and plastic degradation.
Facts
- HQ
- Seattle, WA, USA
- Sectors
- Biotechnology, Protein design, Computational biology, AI/ML
Is this your organization? Claim it
From Idea to Impact: UW Innovators Launch Startups
(https://comotion.uw.edu/) From environmental solutions to biotech breakthroughs, this video spotlights four University of Washington researchers who launched startups to bring their innovations to the world. Their stories offer inspiration—and a roadmap—for UW innovators ready to make an impact. Featured in this video: Cecilia Aragon – Professor, UW Dept. of Human Centered Design & Engineering; Co-founder, Viata Daniel Adriano-Silva – Co-founder & CEO, Monod Bio; Volunteer Translational Advisor, Institute for Protein Design Alexander Gagnon – Associate Professor, UW School of Oceanography; Co-founder & CEO, Banyu Carbon Julian Sachs – Associate Professor, UW School of Oceanography; Co-founder, Banyu Carbon
James Lazarovits - Co-Founder and CEO at Archon Biosciences
James Lazarovits is the CEO and Co-Founder of Archon Biosciences, a leader at the intersection of materials engineering and artificial intelligence. James brings over 15 years of experience building, mentoring, and investing in deep tech startups across AI, software, hardware, and robotics. Before founding Archon, James was at the forefront of AI-driven computational protein design as a post-doctoral fellow and later research faculty at the Institute for Protein Design at the University of Washington, under the direction of 2024 Nobel Laureate, David Baker. There, he contributed to pioneering methods that integrate machine learning and molecular engineering to create next-gen therapeutic…
Archon's Jamie Lazarovits on Unlocking the Full Power of Antibodies With AI
What does it take to move from cutting-edge academic research to launching a biotech company that could transform medicine? In this week's episode of Founded & Funded, Madrona Partner Chris Picardo sat down with Jamie Lazarovitz, CEO and co-founder of Archon Biosciences, to uncover the story behind their groundbreaking protein-based biologics and their unique Antibody Cages (AbCs). From bootstrapping deep tech investments as a student to navigating the challenges of commercializing revolutionary science, Jamie shares the pivotal moments, tough decisions, and key lessons that led to Archon's creation. This isn't just a story for biotech enthusiasts — every founder can…
See all 6 videos about Institute for Protein Design.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events